The kallikrein‐kinin system as a regulator of cardiovascular and renal function
NE Rhaleb, XP Yang… - Comprehensive Physiology, 2011 - Wiley Online Library
Autocrine, paracrine, endocrine, and neuroendocrine hormonal systems help regulate
cardio‐vascular and renal function. Any change in the balance among these systems may …
cardio‐vascular and renal function. Any change in the balance among these systems may …
Mechanisms of disease: the tissue kallikrein–kinin system in hypertension and vascular remodeling
The pathogenesis of arterial hypertension often involves a rise in systemic vascular
resistance (vasoconstriction and vascular remodeling) and impairment of salt excretion in …
resistance (vasoconstriction and vascular remodeling) and impairment of salt excretion in …
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
M Kakoki, RW McGarrah, HS Kim… - Proceedings of the …, 2007 - National Acad Sciences
To explore the role of the kallikrein–kinin system in relation to ischemia/reperfusion injury in
the kidney, we generated mice lacking both the bradykinin B1 and B2 receptor genes …
the kidney, we generated mice lacking both the bradykinin B1 and B2 receptor genes …
[HTML][HTML] The kallikrein–kinin system in health and in diseases of the kidney
M Kakoki, O Smithies - Kidney international, 2009 - Elsevier
Since kallikrein was discovered as a vasodilatory substance in human urine, the kallikrein–
kinin system (KKS) has been considered to play a physiological role in controlling blood …
kinin system (KKS) has been considered to play a physiological role in controlling blood …
Impact of kinins in the treatment of cardiovascular diseases
D Regoli, GE Plante, F Gobeil Jr - Pharmacology & therapeutics, 2012 - Elsevier
In recent years, ACE Inhibitors (ACEIs) and Angiotensin II receptor antagonists (also known
as AT1 receptor antagonists (AT1-RAs), angiotensin receptor blockers (ARBs), or Sartans) …
as AT1 receptor antagonists (AT1-RAs), angiotensin receptor blockers (ARBs), or Sartans) …
HIF-1α preconditioning potentiates antioxidant activity in ischemic injury: the role of sequential administration of dihydrotanshinone I and protocatechuic aldehyde in …
L Jiang, H Zeng, L Ni, L Qi, Y Xu, L Xia… - Antioxidants & Redox …, 2019 - liebertpub.com
Aims: The management of myocardial ischemia has been challenged by reperfusion injury.
Reactive oxygen species (ROS) production is the critical cause of reperfusion injury, but …
Reactive oxygen species (ROS) production is the critical cause of reperfusion injury, but …
The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction
J Chao, G Bledsoe, H Yin, L Chao - 2006 - degruyter.com
Tissue kallikrein (hK1) cleaves low-molecular-weight kininogen to produce kinin peptide,
which binds to kinin receptors and triggers a wide spectrum of biological effects. Tissue …
which binds to kinin receptors and triggers a wide spectrum of biological effects. Tissue …
Kinins and kinin receptors in cardiovascular and renal diseases
JP Girolami, N Bouby, C Richer-Giudicelli… - Pharmaceuticals, 2021 - mdpi.com
This review addresses the physiological role of the kallikrein–kinin system in arteries, heart
and kidney and the consequences of kallikrein and kinin actions in diseases affecting these …
and kidney and the consequences of kallikrein and kinin actions in diseases affecting these …
Plasma kallikrein mediates angiotensin II Type 1 receptor–stimulated retinal vascular permeability
JA Phipps, AC Clermont, S Sinha, TJ Chilcote… - …, 2009 - Am Heart Assoc
Hypertension is a leading risk factor for the development and progression of diabetic
retinopathy and contributes to a variety of other retinal diseases in the absence of diabetes …
retinopathy and contributes to a variety of other retinal diseases in the absence of diabetes …
Selective kinin receptor agonists as cardioprotective agents in myocardial ischemia and diabetes
L Potier, L Waeckel, MP Vincent, C Chollet… - … of Pharmacology and …, 2013 - ASPET
Cardiac ischemia is a leading cause of death, especially in diabetic patients. The diabetic
ischemic heart is resistant experimentally to established cardioprotective treatments. New …
ischemic heart is resistant experimentally to established cardioprotective treatments. New …